Terms: = Breast cancer AND DICER1, Dicer, 23405, ENSG00000100697, KIAA0928, HERNA, Q9UPY3, K12H4_8-LIKE AND Treatment
21 results:
1. Role of tRNA-derived small RNAs(tsRNAs) in the diagnosis and treatment of malignant tumours.
Mao M; Chen W; Huang X; Ye D
Cell Commun Signal; 2023 Jul; 21(1):178. PubMed ID: 37480078
[TBL] [Abstract] [Full Text] [Related]
2. Ovarian epithelioid malignant peripheral nerve sheath tumor with EWSR1-CREM fusion: A case report and literature review.
Li S; Hong R; Wang X; Yang J
Int J Gynaecol Obstet; 2023 Nov; 163(2):521-527. PubMed ID: 37151162
[TBL] [Abstract] [Full Text] [Related]
3. dicer-mediated miR-200b expression contributes to cell migratory/invasive abilities and cancer stem cells properties of breast cancer cells.
Hsu TW; Chen HA; Liao PH; Su YH; Chiu CF; Huang CY; Lin YJ; Hung CC; Yeh MH; Sung SY; Su CM
Aging (Albany NY); 2022 Aug; 14(16):6520-6536. PubMed ID: 35951366
[TBL] [Abstract] [Full Text] [Related]
4. Linoleic-acid-substituted polyethylenimine to silence heat shock protein 90B1 (HSP90B1) to inhibit migration of breast cancer cells.
Meenakshi Sundaram DN; Kc RB; Uludağ H
J Gene Med; 2022 Jun; 24(6):e3419. PubMed ID: 35373897
[TBL] [Abstract] [Full Text] [Related]
5. Rare Hereditary Gynecological cancer Syndromes.
Watanabe T; Soeda S; Endo Y; Okabe C; Sato T; Kamo N; Ueda M; Kojima M; Furukawa S; Nishigori H; Takahashi T; Fujimori K
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163487
[TBL] [Abstract] [Full Text] [Related]
6. lncRNA MALAT1 participates in metformin inhibiting the proliferation of breast cancer cell.
Huang Y; Zhou Z; Zhang J; Hao Z; He Y; Wu Z; Song Y; Yuan K; Zheng S; Zhao Q; Li T; Wang B
J Cell Mol Med; 2021 Aug; 25(15):7135-7145. PubMed ID: 34164906
[TBL] [Abstract] [Full Text] [Related]
7. LncRNA CARMN overexpression promotes prognosis and chemosensitivity of triple negative breast cancer via acting as miR143-3p host gene and inhibiting DNA replication.
Sheng X; Dai H; Du Y; Peng J; Sha R; Yang F; Zhou L; Lin Y; Xu S; Wu Y; Yin W; Lu J
J Exp Clin Cancer Res; 2021 Jun; 40(1):205. PubMed ID: 34162418
[TBL] [Abstract] [Full Text] [Related]
8. Preliminary preclinical study of Chol-DsiRNA polyplexes formed with PLL[30]-PEG[5K] for the RNAi-based therapy of breast cancer.
Ye Z; Abdelmoaty MM; Ambardekar VV; Curran SM; Dyavar SR; Arnold LL; Cohen SM; Kumar D; Alnouti Y; Coulter DW; Singh RK; Vetro JA
Nanomedicine; 2021 Apr; 33():102363. PubMed ID: 33545405
[TBL] [Abstract] [Full Text] [Related]
9. Macrofollicular Variant of Follicular Thyroid Carcinoma (MV-FTC) with a Somatic dicer1 Gene Mutation: Case Report and Review of the Literature.
Hellgren LS; Hysek M; Jatta K; Zedenius J; Juhlin CC
Head Neck Pathol; 2021 Jun; 15(2):668-675. PubMed ID: 32712880
[TBL] [Abstract] [Full Text] [Related]
10. Restoration of miRNA-149 Expression by TmPyP4 Induced Unfolding of Quadruplex within Its Precursor.
Ghosh A; Ekka MK; Tawani A; Kumar A; Chakraborty D; Maiti S
Biochemistry; 2019 Feb; 58(6):514-525. PubMed ID: 30585723
[TBL] [Abstract] [Full Text] [Related]
11. Cellular Delivery of siRNAs Using Bolaamphiphiles.
Gupta K
Methods Mol Biol; 2017; 1632():187-205. PubMed ID: 28730440
[TBL] [Abstract] [Full Text] [Related]
12. [Clinical Efficacy of EPOCH±R Followed by DICE±R Regimen for Primary breast Diffuse Large B-Cell Lymphoma].
Dong LH; Chen JL; Gao X; Li GP; Li YF; Song YP; Wei XD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):766-771. PubMed ID: 28641632
[TBL] [Abstract] [Full Text] [Related]
13. Polymeric Delivery of siRNA against Integrin-β1 (CD29) to Reduce Attachment and Migration of breast cancer Cells.
Meenakshi Sundaram DN; Kucharski C; Parmar MB; Kc RB; Uludağ H
Macromol Biosci; 2017 Jun; 17(6):. PubMed ID: 28160423
[TBL] [Abstract] [Full Text] [Related]
14. MiR-18a upregulation decreases dicer expression and confers paclitaxel resistance in triple negative breast cancer.
Sha LY; Zhang Y; Wang W; Sui X; Liu SK; Wang T; Zhang H
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2201-8. PubMed ID: 27338043
[TBL] [Abstract] [Full Text] [Related]
15. dicer Elicits Paclitaxel Chemosensitization and Suppresses cancer Stemness in breast cancer by Repressing AXL.
Chang TY; Chen HA; Chiu CF; Chang YW; Kuo TC; Tseng PC; Wang W; Hung MC; Su JL
Cancer Res; 2016 Jul; 76(13):3916-28. PubMed ID: 27216190
[TBL] [Abstract] [Full Text] [Related]
16. EpCAM Aptamer-mediated Survivin Silencing Sensitized cancer Stem Cells to Doxorubicin in a breast cancer Model.
Wang T; Gantier MP; Xiang D; Bean AG; Bruce M; Zhou SF; Khasraw M; Ward A; Wang L; Wei MQ; AlShamaileh H; Chen L; She X; Lin J; Kong L; Shigdar S; Duan W
Theranostics; 2015; 5(12):1456-72. PubMed ID: 26681989
[TBL] [Abstract] [Full Text] [Related]
17. EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial cancer.
Subramanian N; Kanwar JR; Kanwar RK; Sreemanthula J; Biswas J; Khetan V; Krishnakumar S
PLoS One; 2015; 10(7):e0132407. PubMed ID: 26176230
[TBL] [Abstract] [Full Text] [Related]
18. Diabetes mellitus is associated with breast cancer: systematic review, meta-analysis, and in silico reproduction.
Zhou Y; Zhang X; Gu C; Xia J
Panminerva Med; 2015 Sep; 57(3):101-8. PubMed ID: 25971328
[TBL] [Abstract] [Full Text] [Related]
19. dicer-mediated upregulation of BCRP confers tamoxifen resistance in human breast cancer cells.
Selever J; Gu G; Lewis MT; Beyer A; Herynk MH; Covington KR; Tsimelzon A; Dontu G; Provost P; Di Pietro A; Boumendjel A; Albain K; Miele L; Weiss H; Barone I; Ando S; Fuqua SA
Clin Cancer Res; 2011 Oct; 17(20):6510-21. PubMed ID: 21878538
[TBL] [Abstract] [Full Text] [Related]
20. Knockdown of dicer in MCF-7 human breast carcinoma cells results in G1 arrest and increased sensitivity to cisplatin.
Bu Y; Lu C; Bian C; Wang J; Li J; Zhang B; Li Z; Brewer G; Zhao RC
Oncol Rep; 2009 Jan; 21(1):13-7. PubMed ID: 19082437
[TBL] [Abstract] [Full Text] [Related]
[Next]
